Replicel CEO to speak in japan today

waynakyo · Feb 18, 2021

yawn.

But for those who are interested the presentation will be available, together with audio, in the link below.

RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference

Kanagawa Regeneration and Cell Medical Industry Network Organizers Invite RepliCel to Participate in Foreign Company Pitch Session

www.biospace.com

A link to RepliCel's presentation (English audio and Japanese text) will be posted shortly after the event. To learn more, visit https://rinkrink.jp/2021.

Armando Jose · Feb 19, 2021

8 minutes, it seems only a presentation of his work
20：49～20：57　Mr. R. Lee Buckler, President & CEO, RepliCel Life Science, Inc. (Canada)
[Bio] Mr. Buckler has been President and CEO of RepliCel Life Sciences since 2016 prior to which he was Vice President of Business Development. Previously he was with Progenitor Cell Therapy, Stem Cell Technologies and the International Society for Cellular Therapy. He has a JD degree from University of British Columbia.
[Business Outline] RepliCel is a cell therapy company focused on aesthetics and orthopedics and is also developing a next-generation dermal injector.

In the same event, a australian firm involved in 3D cell culture, maybe important for us

Dr. Jeremy Dobrowolski, Sales and Business Development, Inventia Life Science Pty Ltd（Australia）
Culturing cells in 2D has been the bedrock of biomedical research for decades because it is simple and efficient. But there is a big problem – cells don’t grow in 2D in the body. It is now well established that 3D cell models better represent human tissues, more accurately replicating biological processes and drug responses. The age of 2D cell culture is over. Implementing physiologically relevant 3D cell models can accelerate discovery and generate high-impact research, but adopting 3D cell culture has not been easy, until now. Inventia Life Science – a leading 3D cell culture startup based in Sydney – has developed the revolutionary RASTRUM platform that makes complex 3D cell biology simple with the power of high-throughput digital 3D bioprinting.